+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07803822

Evaluating MWX203 Injection Alone or With Inclisiran Sodium Injection for Mixed Dyslipidemia in Participants on Stable Statin Therapy

Led by Shanghai Minwei Biotechnology Co., Ltd · Updated on 2026-09-08

216

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter, randomized, double-blind, placebo-controlled Phase 2 study to evaluate the effects of MWX203 Injection alone or combined with Inclisiran Sodium Injection in participants with mixed dyslipidemia who have not achieved adequate lipid control despite stable statin therapy. The study aims to assess the efficacy, safety, pharmacokinetics, and immunogenicity of these treatments. It includes 216 Chinese participants and focuses on the percentage change in serum triglyceride levels as the primary outcome. Participants are assigned to one of five study groups, including three dose levels of MWX203 and a combination therapy group with a fixed dose of Inclisiran. Treatments are given by subcutaneous injection every 12 weeks for a total of two doses during a 36-week double-blind period. Following this, participants whose lipid levels do not return to baseline may enter a 12-week extended follow-up to monitor longer-term effects. During the study, participants will undergo various blood tests to measure changes in triglycerides, LDL cholesterol, total cholesterol, HDL cholesterol, and other lipid markers at multiple time points. Safety is monitored through adverse event reporting and liver fat content is assessed by MRI at selected weeks. Participants are expected to continue stable statin use and attend scheduled visits for assessments throughout the study lasting up to 48 weeks including follow-up.

CONDITIONS

Brief Title

Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed Dyslipidemia

Research Team

W

Wanxiang Chen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here